A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma

Daniel Diolaiti, Filemon S. Dela Cruz, Gunes Gundem, Nancy Bouvier, Mathieu Boulad, Yanming Zhang, Alexander J. Chou, Ira J. Dunkel, Rashesh Sanghvi, Minita Shah, Heather Geiger, Sadia Rahman, Vanessa Felice, Kazimierz O. Wrzeszczynski, Robert B. Darnell, Cristina R. Antonescu, Christopher A. French, Elli Papaemmanuil, Andrew L. Kung, Neerav Shukla

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

NUTM1-rearranged tumors are defined by the presence of a gene fusion between NUTM1 and various gene partners and typically follow a clinically aggressive disease course with poor outcomes despite conventional multimodality therapy. NUTM1-rear-ranged tumors display histologic features of a poorly differentiated carcinoma with areas of focal squamous differentiation and typically express the BRD4-NUTM1 fusion gene defining a distinct clinicopathologic entity-NUT carcinoma (NC). NCs with mesenchymal differentiation have rarely been described in the literature. In this report, we describe the characterization of two cases of high-grade spindle cell sarcoma harboring a novel MGA-NUTM1 fusion. Whole-genome sequencing identified the presence of complex rearrangements resulting in a MGA-NUTM1 fusion gene in the absence of other significant somatic mutations. Genetic rearrangement was confirmed by fluorescence in situ hybridization, and expression of the fusion gene product was confirmed by transcriptomic analysis. The fusion protein was predicted to retain nearly the entire protein sequence of both MGA (exons 1-22) and NUTM1 (exons 3-8). Histopathologically, both cases were high-grade spindle cell sarcomas without specific differentiation markers. In contrast to typical cases of NC, these cases were successfully treated with aggressive local control measures (surgery and radiation) and both patients remain alive without disease. These cases describe a new subtype of NUTM1-rearranged tumors warranting expansion of diagnostic testing to evaluate for the presence of MGA-NUTM1 or alternative NUTM1 gene fusions in the diagnostic workup of high-grade spindle cell sarcomas or small round blue cell tumors of ambiguous lineage.

Original languageEnglish (US)
Article numbera003194
JournalCold Spring Harbor Molecular Case Studies
Volume4
Issue number6
DOIs
StatePublished - Dec 2018

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma'. Together they form a unique fingerprint.

  • Cite this

    Diolaiti, D., Dela Cruz, F. S., Gundem, G., Bouvier, N., Boulad, M., Zhang, Y., Chou, A. J., Dunkel, I. J., Sanghvi, R., Shah, M., Geiger, H., Rahman, S., Felice, V., Wrzeszczynski, K. O., Darnell, R. B., Antonescu, C. R., French, C. A., Papaemmanuil, E., Kung, A. L., & Shukla, N. (2018). A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma. Cold Spring Harbor Molecular Case Studies, 4(6), [a003194]. https://doi.org/10.1101/mcs.a003194